Simulated proof asset · India diabetology · HbA1c + foot-care follow-up + DPDP-aware evidence

Simulated India diabetology HbA1c + foot-care follow-up DPDP diagnostic

This no-fake-client proof asset shows how AICS can inspect workflow leakage around diabetes consult calls, HbA1c report follow-ups, old-patient recalls, foot-care notes, refill questions, camp leads, dietician no-shows, retinopathy referrals and post-discharge reviews. It is synthetic only: no real diabetology clinic, no real doctor, no real patient, no PHI, no customer data, no production export, no DPDP compliance claim, no medical outcome, no appointment lift, no no-show reduction, no revenue or ROI claim is made.

Important claim boundary: this page is a simulated proof-of-method demonstration. It is not a customer case study, not a testimonial, not a customer-data analysis, and makes no real clinic, no real doctor, no real patient, no PHI, no medical advice, no legal advice, no privacy advice, no security advice, no DPDP compliance claim, no HbA1c outcome claim, no wound-care outcome claim, no appointment growth, no no-show reduction, no ranking, no revenue and no ROI promise.
Synthetic rows12diabetology workflow sample
Monthly items represented1,754synthetic volume only
Callback coverage34.6%source-log synthetic arithmetic
Admin-safe rows1after consent and clinical checks
HbA1c logging coverage27.9%synthetic follow-up evidence
Foot-care logging coverage25.0%synthetic follow-up evidence
Consent-not-ready rows10notice/opt-in/boundary gaps
Human-review rows9clinical, medication or red-flag routing
Diagnostic method

What a diabetology owner can inspect before buying another reminder bot or AI receptionist

The diagnostic converts HbA1c, foot-care and diabetes follow-up rows into operating queues: source, owner, consent notice, WhatsApp opt-in, AI/admin boundary disclosure, queue age, clinical escalation, blocker and next safe action.

Evidence/control areaSynthetic volume or stateWhy AICS would flag it
Admin-safe follow-up1 candidateOnly appointment/callback logistics with consent and no clinical question should move toward automation.
Clinician-review boundary9 rowsHbA1c interpretation, medication/refill changes, CGM/insulin pump questions, foot numbness/wound care and red-flag symptoms require qualified human review.
Owner ageing6 rows idle for 24h+Clinic owners need named owner, queue age and next-safe-action visibility before judging staffing or automation.
Consent and boundary readiness10 rows not readyWhatsApp, call, SMS or AI-assisted admin follow-up needs consent, notice and boundary evidence reviewed with appropriate advisers.
HbA1c report follow-up743 due items; 27.9% logging coverageReport-photo and interpretation queues must not be treated as generic marketing reminders.
Foot-care risk follow-up188 risk items; 25.0% logging coverageFoot numbness, wound-care and post-discharge signals need escalation evidence, not automated medical guidance.

Before diagnostic

  • HbA1c report photos, old-patient recalls, foot-care notes, refill calls, camp lists and post-discharge reviews sit in one unsegmented follow-up list.
  • Notice, WhatsApp opt-in, owner ageing, clinical boundary and escalation evidence are easy to miss.
  • Automation decisions risk sending unsafe or incomplete clinical-context communication.

After diagnostic operating rule

  • Each row has queue type, owner role, ageing, evidence gap and next safe action.
  • HbA1c interpretation, medication/refill changes, foot-care and red-flag symptom rows route to clinician review before automation.
  • The result is an owner action backlog, not a DPDP certificate, clinical outcome claim or revenue promise.

Evidence needed before publishing any real diabetology outcome

A real pilot should request only permissioned, minimized and redacted operational exports; define source, owner, consent notice, WhatsApp opt-in, boundary disclosure, queue age, blocker, escalation and next-safe-action fields; and obtain explicit clinic approval plus qualified medical, legal, privacy and security review before any public patient, DPDP, clinical, appointment, no-show, revenue or ROI statement.

  • Synthetic data only
  • No patient or PHI data
  • No medical advice
  • No DPDP compliance claim
  • No revenue or ROI claim

Reproducibility

Internal synthetic artifact: /home/agent/.hermes/aicloudstrategist/case-studies/simulated-india-diabetology-hba1c-footcare-followup-dpdp-2026-08-27/. Expected headline output: rows=12, synthetic_monthly_items=1754, callback_coverage_pct=34.6, hba1c_followup_logging_pct=27.9, footcare_followup_logging_pct=25.0, consent_not_ready_rows=10, owner_gap_rows=3, stale_24h_rows=6, human_review_rows=9, red_flag_rows=2, admin_safe_rows=1. Input SHA256 14f28be521d5872f2717214bd68691597dc96569457d098e6dc8b7e58d2649e9; generator SHA256 d6b5aecd94a32efedebfedc0374613840212334822a6f676c3edeb7ccbd01640; report SHA256 223656a03237c86a4459e5d7760f4e1fb19eb49911f97c0c9a9c541897b73b74.

More proof assets · Healthcare GrowthOS · Clinic follow-up checklist